115 related articles for article (PubMed ID: 3875589)
1. Steroids reduce complement activation in rheumatoid arthritis.
Brandslund I; Peters ND; Ejstrup L
Int J Tissue React; 1985; 7(2):161-5. PubMed ID: 3875589
[TBL] [Abstract][Full Text] [Related]
2. Reduction of complement activation in rheumatoid arthritis by steroid treatment.
Ernst E; Espersen GT; Andersen MV
Int J Tissue React; 1990; 12(2):77-9. PubMed ID: 2170287
[TBL] [Abstract][Full Text] [Related]
3. Activation of classical pathway complement in chronic inflammation. Elevated levels of circulating C3d and C4d split products in rheumatoid arthritis and Crohn's disease.
Petersen NE; Elmgreen J; Teisner B; Svehag SE
Acta Med Scand; 1988; 223(6):557-60. PubMed ID: 3389208
[TBL] [Abstract][Full Text] [Related]
4. Complement activation in patients with rheumatoid arthritis mediated in part by C-reactive protein.
Molenaar ET; Voskuyl AE; Familian A; van Mierlo GJ; Dijkmans BA; Hack CE
Arthritis Rheum; 2001 May; 44(5):997-1002. PubMed ID: 11352263
[TBL] [Abstract][Full Text] [Related]
5. Infliximab treatment reduces complement activation in patients with rheumatoid arthritis.
Familian A; Voskuyl AE; van Mierlo GJ; Heijst HA; Twisk JW; Dijkmans BA; Hack CE
Ann Rheum Dis; 2005 Jul; 64(7):1003-8. PubMed ID: 15958758
[TBL] [Abstract][Full Text] [Related]
6. [Complement fragment C 3d in the plasma of patients with chronic polyarthritis].
Stannat S; Peter HH; Raspe HH; Deicher H
Z Rheumatol; 1986; 45(2):47-51. PubMed ID: 3487899
[TBL] [Abstract][Full Text] [Related]
7. Correlation in rheumatoid arthritis of concentrations of plasma C3d, serum rheumatoid factor, immune complexes and C-reactive protein with each other and with clinical features of disease activity.
Mallya RK; Vergani D; Tee DE; Bevis L; de Beer FC; Berry H; Hamilton ED; Mace BE; Pepys MB
Clin Exp Immunol; 1982 Jun; 48(3):747-53. PubMed ID: 6981476
[TBL] [Abstract][Full Text] [Related]
8. The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.
Bourke BE; Moss IK; Mumford P; Horsfall A; Maini RN
Clin Exp Immunol; 1982 Jun; 48(3):726-32. PubMed ID: 6981475
[TBL] [Abstract][Full Text] [Related]
9. [Serum complement levels in patients with rheumatoid arthritis and vasculitis].
Tomooka K
Fukuoka Igaku Zasshi; 1989 Oct; 80(10):456-66. PubMed ID: 2613159
[TBL] [Abstract][Full Text] [Related]
10. Steroids and complement activation in rheumatoid arthritis.
Brandslund I; Peters ND; Ejstrup L; Teisner B; Rasmussen GG
Lancet; 1983 Aug; 2(8345):346-7. PubMed ID: 6135865
[No Abstract] [Full Text] [Related]
11. Studies on the haemolytic activity of circulating C1q-C3/C4 complexes.
Wouters D; Brouwer MC; Daha MR; Hack CE
Mol Immunol; 2008 Apr; 45(7):1893-9. PubMed ID: 18054386
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of classical complement pathway activation in rheumatoid arthritis: measurement of C1q-C4 complexes as novel activation products.
Wouters D; Voskuyl AE; Molenaar ET; Dijkmans BA; Hack CE
Arthritis Rheum; 2006 Apr; 54(4):1143-50. PubMed ID: 16572449
[TBL] [Abstract][Full Text] [Related]
13. Complement C3c and C3d in plasma and synovial fluid in rheumatoid arthritis.
Berkowicz A; Kappelgaard E; Petersen J; Nielsen H; Ingemann-Hansen T; Halkjaer-Kristensen J; Sørensen H
Acta Pathol Microbiol Immunol Scand C; 1983 Dec; 91(6):397-402. PubMed ID: 6608857
[TBL] [Abstract][Full Text] [Related]
14. Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation.
Wouters D; Wiessenberg HD; Hart M; Bruins P; Voskuyl A; Daha MR; Hack CE
J Immunol Methods; 2005 Mar; 298(1-2):35-45. PubMed ID: 15847795
[TBL] [Abstract][Full Text] [Related]
15. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.
Hepburn AL; Mason JC; Davies KA
Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618
[TBL] [Abstract][Full Text] [Related]
16. Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway.
Makinde VA; Senaldi G; Jawad AS; Berry H; Vergani D
Ann Rheum Dis; 1989 Apr; 48(4):302-6. PubMed ID: 2785367
[TBL] [Abstract][Full Text] [Related]
17. [Elevated C3-proactivator serum levels in patients with chronic polyarthritis].
Stojan B
Z Rheumatol; 1976; 35(7-8):272-7. PubMed ID: 961078
[TBL] [Abstract][Full Text] [Related]
18. [Complement (C3)-activating material in synovial fluid from patients with rheumatoid arthritis].
Stojan B
Z Rheumatol; 1981; 40(5):208-12. PubMed ID: 6914866
[TBL] [Abstract][Full Text] [Related]
19. Alternative pathway complement activation in rheumatoid arthritis.
El-Ghobarey A; Whaley K
J Rheumatol; 1980; 7(4):453-60. PubMed ID: 6158571
[TBL] [Abstract][Full Text] [Related]
20. Complement activation in bronchial asthma evaluated by the C3d/C3 index.
Michel O; Sergysels R; Duchateau J
Ann Allergy; 1986 Dec; 57(6):405-8. PubMed ID: 3491553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
